Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 04 2021
26 04 2021
Historique:
received:
03
01
2021
accepted:
07
04
2021
entrez:
27
4
2021
pubmed:
28
4
2021
medline:
16
11
2021
Statut:
epublish
Résumé
To evaluate intraocular pressure (IOP) and choroidal thickness (ChT) postural changes in multiple system atrophy (MSA), Parkinson's disease (PD) patients and healthy controls (HC). 20 MSA patients, 21 PD patients and 14 HC, were examined. All subjects underwent a complete examination, including corneal thickness, ChT, IOP and axial length (AL) measurements. IOP measurement was performed in supine, sitting, and standing positions, whereas ChT in sitting and standing positions. Supine to standing IOP variations were significantly higher in MSA vs PD(p = 0.01) and in MSA vs HC (p < 0.0001), whereas no significant differences were observed between PD and HC (p = 0.397). Mean sub-foveal ChT in MSA was 240 ± 92 μm in sitting position, and 215 ± 94 μm in standing position with a significant reduction (p = 0.008). Mean sub-foveal ChT in PD was 258 ± 79 μm in sitting position, and 259 ± 76 μm in standing position (p = 0.887). In HC it was 244 ± 36 μm in sitting position, and 256 ± 37 μm in standing position with a significant increase (p = 0.007). The significant IOP and ChT postural changes can be considered additional hallmarks of autonomic dysfunction in MSA and further studies are needed to consider them as biomarkers in the differential diagnosis with PD.
Identifiants
pubmed: 33903644
doi: 10.1038/s41598-021-88250-3
pii: 10.1038/s41598-021-88250-3
pmc: PMC8076309
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8936Références
Neurology. 2008 Jan 29;70(5):368-73
pubmed: 18227417
Surv Ophthalmol. 1994 May;38 Suppl:S191-7
pubmed: 7940143
Cell Mol Neurobiol. 2003 Oct;23(4-5):519-26
pubmed: 14514012
Br J Ophthalmol. 2020 Jun;104(6):790-794
pubmed: 31519546
Exp Eye Res. 1994 May;58(5):529-43
pubmed: 7925690
Ann Neurol. 2004 Mar;55(3):418-22
pubmed: 14991820
Invest Ophthalmol Vis Sci. 1987 Aug;28(8):1346-52
pubmed: 3610552
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Neuroradiol J. 2019 Jun;32(3):227-228
pubmed: 30793659
Mov Disord. 1997 Mar;12(2):133-47
pubmed: 9087971
Neurology. 2002 Sep 24;59(6):944-6
pubmed: 12297588
Semin Ophthalmol. 2016;31(3):233-42
pubmed: 25334042
Surv Ophthalmol. 2010 Sep-Oct;55(5):445-53
pubmed: 20637484
Trans Am Ophthalmol Soc. 1982;80:391-474
pubmed: 6763801
Neurology. 2006 Feb 14;66(3):378-83
pubmed: 16476936
Exp Eye Res. 1987 Nov;45(5):665-72
pubmed: 3428392
Medicina (Kaunas). 2019 Oct 18;55(10):
pubmed: 31635406
Auton Neurosci. 2010 Dec 8;158(1-2):111-7
pubmed: 20732833
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5151-5156
pubmed: 28986593
Auton Neurosci. 2002 Feb 28;96(1):59-62
pubmed: 11911503
Neuropathol Appl Neurobiol. 2016 Feb;42(1):20-32
pubmed: 26785838
J Neurol. 2002 Jun;249(6):712-8
pubmed: 12111304
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Acta Neuropathol. 2007 Sep;114(3):201-11
pubmed: 17593377
Circulation. 2003 Nov 11;108(19):2349-54
pubmed: 14597588
Optom Vis Sci. 2019 Jul;96(7):477-483
pubmed: 31274735
N Engl J Med. 2015 Jan 15;372(3):249-63
pubmed: 25587949
Am J Ophthalmol. 1987 Apr 15;103(4):523-6
pubmed: 3565513
Int J Ophthalmol. 2018 Jan 18;11(1):94-100
pubmed: 29375998
Am J Ophthalmol. 2018 Nov;195:243
pubmed: 30149890
Ophthalmology. 2013 Jan;120(1):175-80
pubmed: 23009895
Ophthalmic Res. 1992;24(6):338-43
pubmed: 1287513
J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1645-8
pubmed: 16291887